foxo4-dri vs gdf-11 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Buy FOXO4-DRI (Proxofim) - Senolytic
Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Structural basis for potency differences between GDF8 and GDF11 BMC Biology Springer Nature Link
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



